CCA
FPRX

Column Capital Advisors’s Five Prime Therapeutics, Inc. FPRX Stock Holding History

Column Capital Advisors’s Portfolio FPRX Stock Details FPRX Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2021
Q2 		– Sell
-50
Closed -$2K – 748
2021
Q1 		$2K Hold
50
– – ﹤0.01% 646
2020
Q4 		$1K Hold
50
– – ﹤0.01% 695
2020
Q3 		$0 Hold
50
– – ﹤0.01% 907
2020
Q2 		$0 Hold
50
– – ﹤0.01% 944
2020
Q1 		$0 Buy
+50
New +$212 ﹤0.01% 820

Column Capital Advisors's FPRX Position: Q2 2021 in Review

Column Capital Advisors sold out of Five Prime Therapeutics, Inc. (FPRX) in Q2 2021, closing a stake of 50 shares — an estimated $2K sold.

Column Capital Advisors first reported a position in FPRX in Q1 2020 and held it in 5 quarters. The position peaked at $2K in Q1 2021. 0 funds tracked by Wall St. Rank hold FPRX as of Q2 2021.

  • Column Capital Advisors reported no remaining Five Prime Therapeutics, Inc. position as of Q2 2021 after selling out during the quarter.
  • Column Capital Advisors sold 50 Five Prime Therapeutics, Inc. shares in Q2 2021, an estimated $2K.
  • Column Capital Advisors first reported a position in Five Prime Therapeutics, Inc. in Q1 2020 and held it in 5 quarters.
  • Column Capital Advisors's Five Prime Therapeutics, Inc. position peaked at $2K in Q1 2021.
  • 0 funds tracked by Wall St. Rank held Five Prime Therapeutics, Inc. as of Q2 2021.

Based on Column Capital Advisors's 13F filing for Q2 2021, filed 5 Aug 2021.